Free shipping on all orders over $ 500

LHRH/GnRH Gonadotropin releasing hormone/Luteinizing hormone releasing hormone

Cat.No.  Name Information
M5735 Leuprolide Acetate Leuprolide acetate is a GnRH analog; leuprolide acetate acts as an agonist at pituitary GnRH receptors.
M53128 Degarelix acetate hydrate Degarelix acetate hydrate is a competitive and reversible gonadotropin-releasing hormone receptor (GnRHR/LHRHR) antagonist.
M53114 LHRH LHRH, the luteinizing hormone-releasing hormone, is a neuropeptide hypothalamic.
M45271 Ganirelix acetate Ganirelix acetate is a competitive gonadotropin-releasing hormone (GnRH) antagonist that directly binds to endogenous molecules competing for the receptor and causes a rapid decrease in estradiol levels. Ganirelix acetate can be used in studies related to ovarian hyperstimulation syndrome (OHSS) and preterm labor.
M31385 Gonadorelin acetate Gonadorelin acetate is a decameric synthetic oligopeptide that is also a gonadotropin-releasing hormone (GnRH) agonist.
M31382 Triptorelin acetate Triptorelin acetate is a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) and a gonadotropin-releasing hormone (GnRH) agonist.
M30666 (R)-Elagolix Elagolix is a highly potent, selective, orally-active, short-duration, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM). Target: GnRH in vitro: Elagolix is a short-acting, nonpeptide, GnRH antagonist, administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose-dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full suppression at higher doses. Elagolix is regarded as the frontrunner of a new class of GnRH inhibitors that have been denoted as second-generation, due to their non-peptide nature and oral bioavailability.
M22414 Buserelin Acetate Buserelin Acetate
M22196 Degarelix acetate Degarelix acetate is a decapeptide that shows high affinity/selectivity to human gonadotropin-releasing hormone (GnRH) receptor (IC50 = 3 nM).
M21021 Nafarelin Acetate Nafarelin Acetate is a Gonadotropin-releasing hormone (GnRH) agonist; synthetic decapeptide analog of GnRH (luteinizing hormone-releasing hormone, gonadorelin); structurally related to goserelin, leuprolide, and triptorelin.
M21020 Leuprorelin Leuprorelin is a natriuretic peptide analog of GnRH and a pituitary GnRH receptor agonist. It can be used in studies related to estrogen receptor (ER)-positive premenopausal breast cancer.
M13378 Antide Sequence:Ac-D2Nal-DCpa-DPal-Ser-Lys(nicotinoyl)-DLys(nicotinoyl)-Leu-Lys(isopropyl)-Pro-DAla-NH2
M13376 Abarelix Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence:Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2
M13375 Cetrorelix Acetate Cetrorelix Acetate (SB-75 acetate) is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM. Sequence:Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-DCit-Leu-Arg-Pro-DAla-NH2
M13374 Ganirelix Sequence: Ac-D-2-Nal-D-Phe(4-Cl)-D-3-Pal-Ser-Tyr-D-Lys(C(NHEt)2)-Leu-Lys(C(NHEt)2)-Pro-D-Ala-NH2
M10505 Histrelin acetate Histrelin is a nonapeptide analog of GnRH (gonadotropin-releasing hormone) with added potency.
M10477 Linzagolix Linzagolix is a novel potent, orally active gonadotropin-releasing hormone (GnRH) antagonist.
M10250 Degarelix (GSK1278863) Degarelix (GSK1278863) is a third generation antagonist of luteinizing hormone-releasing hormone (LHRH, also termed gonadotropin-releasing hormone) for the first-line treatment of androgen-dependent advanced prostate cancer.
M9197 Relugolix Relugolix, also known as TAK-385, is an orally active gonadotropin-releasing hormone (GnRH) antagonist with an IC50 of 0.12 nM.
M5391 Alarelin Acetate Alarelin acetate is a synthetic GnRH agonist. Alarelin is found in higher amounts than that of LH-RH in rat hypophyseal stimulation of gonadotropin secretion in vivo and in vitro and in ovulation inductions.




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.